Corticosteroid-free maintenance immunosuppression after heart transplantation: feasibility and beneficial effects.
Price
G D
GD
Utah Transplantation Affiliated Hospitals (UTAH), Cardiac Transplant Program, Salt Lake City.
Olsen
S L
SL
Taylor
D O
DO
O'Connell
J B
JB
Bristow
M R
MR
Renlund
D G
DG
D003327:Coronary Disease / Q000139:chemically induced; D005260:Female; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006084:Graft Rejection; D016027:Heart Transplantation; D006801:Humans; D006937:Hypercholesterolemia / Q000139:chemically induced; D006973:Hypertension / Q000139:chemically induced; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D008775:Methylprednisolone / Q000009:adverse effects*; D008875:Middle Aged; D011241:Prednisone / Q000009:adverse effects*; D012189:Retrospective Studies; D013375:Substance Withdrawal Syndrome; D015430:Weight Gain
D007166:Immunosuppressive Agents; D011241:Prednisone; D008775:Methylprednisolone